Patents by Inventor Michael Karas

Michael Karas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150358160
    Abstract: A method, system and apparatus for deriving a secondary secret from a root secret are described, the method, system and apparatus including reserving a memory buffer included in an integrated circuit, the memory buffer being large enough to contain all of the bits which will include the secondary secret, receiving a plurality of bits from a root secret, the root secret being stored in a secure memory of the integrated circuit, inputting the plurality of bits from the root secret and at least one control bit into a permutation network, and thereby producing a multiplicity of output bits, the at least one control bit including one of one bit of a value g, and one bit an output of a function which receives g as an input, receiving the multiplicity of output bits from the permutation network, inputting the multiplicity of output bits from the permutation network into a plurality of logic gates, thereby combining the multiplicity of output bits, wherein a fixed number of bits is output from the logic gates, inputt
    Type: Application
    Filed: July 10, 2013
    Publication date: December 10, 2015
    Inventors: Michael KARA-IVANOV, Aviad KIPNIS, Tzachy REINMAN, Efraim MANGELL, Erez WAISBARD, Yaacov BELENKY
  • Publication number: 20150280906
    Abstract: A method for protecting encoded data from algebraic manipulation includes receiving a data word s?Kd to be protected, randomly selecting two integers a?{0, . . . , q?1} and b?{0, . . . , ?q?1}, finding a point (?, ?) on a Hermitian curve over a field Fq that corresponds to the randomly selected integers (a, b) from a mapping (a, b)(?, ?)=(ua, ua?q+1z+vb), where u a := { 0 if ? ? a = 0 , ? 1 a - 1 otherwise , ? ? V b := { 0 if ? ? b = 0 , ? 2 b - 1 otherwise , and z is an element of the field Fq of unit trace, and where ?1 is a fixed primitive element of the field Fq and ?2 is a primitive element of a field F?q?Fq, and calculating a sum fs(?, ?)=?id+1?jd+1+?k=1d?ik?kjk or a set of d+1 integers pairs I={(ik,jk)}k=1d+1, where the encoded word is a triple (s, (?, ?),fs(?, ?)).
    Type: Application
    Filed: March 27, 2014
    Publication date: October 1, 2015
    Applicant: SAMSUNG ISRAEL RESEARCH CORPORATION
    Inventors: YARON SHANY, Shay Landis, Elona Erez, Avner Dor, Michael Kara-Ivanov, Moshe Twitto, Jun Jin Kong
  • Patent number: 8980642
    Abstract: The present invention relates to the use of cyanocinnamic acid derivatives as a matrix in the MALDI mass spectrometry of an analyte.
    Type: Grant
    Filed: July 10, 2008
    Date of Patent: March 17, 2015
    Assignee: Sigma-Aldrich International GmbH
    Inventors: Michael Karas, Thorsten Wolfgang Jaskolla
  • Publication number: 20130040395
    Abstract: The present invention relates to the use of a halogenated cyanocinnamic acid derivative with the general formula: wherein R is selected independently among F, Cl and Br, n=3, 4 or 5 and R? is selected among COOH, CONH2, SO3H and COOR? with R?=C1-O5-Alkyl; and/or of 4-bromo-?-cyanocinnamic acid and/or of ?-cyano-2,4-dichlorocinnamic acid in a matrix for a MALDI mass spectrometry of an analyte.
    Type: Application
    Filed: March 2, 2011
    Publication date: February 14, 2013
    Applicant: JOHANN WOLFGANG GOETHE-UNIVERSITÄT
    Inventors: Thorsten Jaskolla, Michael Karas
  • Patent number: 8131374
    Abstract: The electrical nerve stimulation unit in accordance with the present invention generally includes a housing, an input panel, a display panel, a controller, a first channel output, a second channel output, and a power system. While the device is generally described in terms of use as a TENS unit, it must be noted that other nerve stimulation applications for the device are envisioned as well. The myriad of intelligent and proactive programmable software functions and features of the present invention are executed on the controller's microprocessor. For instance, open lead monitoring, soft recovery implementation, compliance monitoring, and enhanced power management are all controlled and monitored through the interfacing of the processor with the various devices and hardware on the unit's hardware platform.
    Type: Grant
    Filed: August 5, 2011
    Date of Patent: March 6, 2012
    Assignee: Encore Medical Asset Corporation
    Inventors: Gary L. Moore, John Czech, Bisrat Woldegiorges, Michael Karas
  • Publication number: 20110288616
    Abstract: The electrical nerve stimulation unit in accordance with the present invention generally includes a housing, an input panel, a display panel, a controller, a first channel output, a second channel output, and a power system. While the device is generally described in terms of use as a TENS unit, it must be noted that other nerve stimulation applications for the device are envisioned as well. The myriad of intelligent and proactive programmable software functions and features of the present invention are executed on the controller's microprocessor. For instance, open lead monitoring, soft recovery implementation, compliance monitoring, and enhanced power management are all controlled and monitored through the interfacing of the processor with the various devices and hardware on the unit's hardware platform.
    Type: Application
    Filed: August 5, 2011
    Publication date: November 24, 2011
    Inventors: Gary L. Moore, John Czech, Bisrat Woldegiorges, Michael Karas
  • Publication number: 20110288601
    Abstract: The electrical nerve stimulation unit in accordance with the present invention generally includes a housing, an input panel, a display panel, a controller, a first channel output, a second channel output, and a power system. While the device is generally described in terms of use as a TENS unit, it must be noted that other nerve stimulation applications for the device are envisioned as well. The myriad of intelligent and proactive programmable software functions and features of the present invention are executed on the controller's microprocessor. For instance, open lead monitoring, soft recovery implementation, compliance monitoring, and enhanced power management are all controlled and monitored through the interfacing of the processor with the various devices and hardware on the unit's hardware platform.
    Type: Application
    Filed: August 5, 2011
    Publication date: November 24, 2011
    Inventors: Gary L. Moore, John Czech, Bisrat Woldegiorges, Michael Karas
  • Patent number: 8019426
    Abstract: The electrical nerve stimulation unit in accordance with the present invention generally includes a housing, an input panel, a display panel, a controller, a first channel output, a second channel output, and a power system. While the device is generally described in terms of use as a TENS unit, it must be noted that other nerve stimulation applications for the device are envisioned as well. The myriad of intelligent and proactive programmable software functions and features of the present invention are executed on the controller's microprocessor. For instance, open lead monitoring, soft recovery implementation, compliance monitoring, and enhanced power management are all controlled and monitored through the interfacing of the processor with the various devices and hardware on the unit's hardware platform.
    Type: Grant
    Filed: July 16, 2007
    Date of Patent: September 13, 2011
    Assignee: Encore Medical Asset Corporation
    Inventors: Gary L. Moore, John Czech, Bisrat Woldegiorges, Michael Karas
  • Publication number: 20110121166
    Abstract: The present invention relates to the use of cyanocinnamic acid derivatives as a matrix in the MALDI mass spectrometry of an analyte.
    Type: Application
    Filed: July 10, 2008
    Publication date: May 26, 2011
    Inventor: Michael Karas
  • Publication number: 20100167410
    Abstract: The invention relates to a mass spectrometric method for the detection and for the quantification of double stranded nucleic acids which are not covalently associated with one another.
    Type: Application
    Filed: December 7, 2007
    Publication date: July 1, 2010
    Applicants: BioSpring Gesellschaft für Biotechnologie mbH, Johann Wolfgang Goethe-Universität Frankfurt am Main
    Inventors: Huseyin Aygün, Michael Karas, Ute Bahr
  • Publication number: 20100016392
    Abstract: In one aspect, this invention relates to a substantially water-insoluble pesticidal aggregate produced from a mixture comprising: (a) a polymer having at least three similarly charged electrostatic moieties; (b) an amphiphilic surfactant having at least one electrostatically charged moiety of opposite charge to the polymer; and (c) a pesticide. In other aspects, this invention relates pesticidal compositions comprising such a pesticidal aggregate and an agriculturally acceptable carrier, as well as to a method of controlling pests using such pesticidal compositions.
    Type: Application
    Filed: December 13, 2007
    Publication date: January 21, 2010
    Applicant: Innovaform Technologies, LLC
    Inventors: Alexander V. Kabanov, Michael Karas, Tatiana K. Bronitch, Robin Dexter
  • Publication number: 20090306003
    Abstract: An improved pesticide delivery system is disclosed. The system is based on a microblend comprising (a) an amphophilic compound containing at least one hydrophilic group and at least one hydrophobic group and (b) a second compound. Compositions based on the microblend and methods of using the compositions to control pests are also disclosed.
    Type: Application
    Filed: January 10, 2007
    Publication date: December 10, 2009
    Applicant: Innovation Technologies, LLC
    Inventors: Alexander V. Kabanov, Tatiana K. Bronitch, Michael Karas, Bruce L. Frank
  • Publication number: 20090137667
    Abstract: An improved pesticide delivery system is disclosed. The system is based on a microblend comprising (a) an amphiphilic compound containing at least one hydrophilic group and at least one hydrophobic group and (b) a pesticide. Compositions based on the microblend and methods of using the compositions to control pests are also disclosed.
    Type: Application
    Filed: January 10, 2007
    Publication date: May 28, 2009
    Applicant: Innovaform Technologies, LLC
    Inventors: Alexander V. Kabanov, Tatiana K. Bronitch, Michael Karas
  • Publication number: 20090081791
    Abstract: An amino acid sequence Arg-Lys-Met-Leu-Lys-Ser-Thr-Arg-Arg-Gln-Arg-Arg (SEQ ID NO:1) functions as a protein transduction domain (PTD) and is capable of delivering small molecules, proteins, and nucleic acids to an intracellular compartment of a cell. An amino terminal lysine linker improves the efficiency of the PTD. A nuclear localization signal can be used to target the PTD to a cell's nucleus. The PTD can be used in PTD-cargo moiety complexes that can reversibly immortalize cells and increase cell viability in culture.
    Type: Application
    Filed: June 24, 2008
    Publication date: March 26, 2009
    Applicant: Lonza Walkersville, Inc.
    Inventor: Michael Karas
  • Patent number: 7420031
    Abstract: An amino acid sequence Arg-Lys-Met-Leu-Lys-Ser-Thr-Arg-Arg-Gln-Arg-Arg (SEQ ID NO:1) functions as a protein transduction domain (PTD) and is capable of delivering small molecules, proteins, and nucleic acids to an intracellular compartment of a cell. An amino terminal lysine linker improves the efficiency of the PTD. A nuclear localization signal can be used to target the PTD to a cell's nucleus. The PTD can be used in PTD-cargo moiety complexes that can reversibly immortalize cells and increase cell viability in culture.
    Type: Grant
    Filed: December 28, 2005
    Date of Patent: September 2, 2008
    Assignee: Lonza Walkersville, Inc.
    Inventor: Michael Karas
  • Publication number: 20080114414
    Abstract: The electrical nerve stimulation unit in accordance with the present invention generally includes a housing, an input panel, a display panel, a controller, a first channel output, a second channel output, and a power system. While the device is generally described in terms of use as a TENS unit, it must be noted that other nerve stimulation applications for the device are envisioned as well. The myriad of intelligent and proactive programmable software functions and features of the present invention are executed on the controller's microprocessor. For instance, open lead monitoring, soft recovery implementation, compliance monitoring, and enhanced power management are all controlled and monitored through the interfacing of the processor with the various devices and hardware on the unit's hardware platform.
    Type: Application
    Filed: July 16, 2007
    Publication date: May 15, 2008
    Inventors: Gary L. Moore, John Czech, Bisrat Woldegiorges, Michael Karas
  • Patent number: 7254444
    Abstract: The electrical nerve stimulation unit in accordance with the present invention generally includes a housing, an input panel, a display panel, a controller, a first channel output, a second channel output, and a power system. While the device is generally described in terms of use as a TENS unit, it must be noted that other nerve stimulation applications for the device are envisioned as well. The myriad of intelligent and proactive programmable software functions and features of the present invention are executed on the controller's microprocessor. For instance, open lead monitoring, soft recovery implementation, compliance monitoring, and enhanced power management are all controlled and monitored through the interfacing of the processor with the various devices and hardware on the unit's hardware platform.
    Type: Grant
    Filed: October 17, 2002
    Date of Patent: August 7, 2007
    Assignee: Encore Medical Asset Corporation
    Inventors: Gary L. Moore, John Czech, Bisrat Woldegiorges, Michael Karas
  • Patent number: 7166692
    Abstract: An amino acid sequence Arg-Lys-Met-Leu-Lys-Ser-Thr-Arg-Arg-Gln-Arg-Arg (SEQ ID NO:1) functions as a protein transduction domain (PTD) and is capable of delivering small molecules, proteins, and nucleic acids to an intracellular compartment of a cell. An amino terminal lysine linker improves the efficiency of the PTD. A nuclear localization signal can be used to target the PTD to a cell's nucleus. The PTD can be used in PTD-cargo moiety complexes that can reversibly immortalize cells and increase cell viability in culture.
    Type: Grant
    Filed: March 3, 2004
    Date of Patent: January 23, 2007
    Assignee: Canbrex Bio Science Walkersville, Inc.
    Inventor: Michael Karas
  • Publication number: 20060106197
    Abstract: An amino acid sequence Arg-Lys-Met-Leu-Lys-Ser-Thr-Arg-Arg-Gln-Arg-Arg (SEQ ID NO:1) functions as a protein transduction domain (PTD) and is capable of delivering small molecules, proteins, and nucleic acids to an intracellular compartment of a cell. An amino terminal lysine linker improves the efficiency of the PTD. A nuclear localization signal can be used to target the PTD to a cell's nucleus. The PTD can be used in PTD-cargo moiety complexes that can reversibly immortalize cells and increase cell viability in culture.
    Type: Application
    Filed: December 28, 2005
    Publication date: May 18, 2006
    Inventor: Michael Karas
  • Patent number: 7015462
    Abstract: A process for separation of components of a sample in an ion mobility spectrometer using a supply of selectively interactive gaseous particles. The components to be separated carry out selective interaction processes in a drift tube of the ion mobility spectrometer with specifically selected particles, in particular enantiometric collision molecules, which are supplied to a gas inlet, in such a way that they exhibit different rates of mobility during their drift from a sample inlet through the drift tube to an ion collector. This enables the ions to be detected in the ion collector in a time-delayed manner.
    Type: Grant
    Filed: May 28, 2002
    Date of Patent: March 21, 2006
    Inventor: Michael Karas